Speaker Emanuel "Chris" Welch Kicks off Pride Month with a Celebration for all on June 1   •   Cellular Origins Launches Constellation, Its Configurable Robotic Platform to Enable Scalable Manufacture of Advanced Therapies   •   THERALINK INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Theralin   •   Genomic Testing Cooperative Presents at ASCO meeting Studies Demonstrating the Power of its Liquid Biopsy and Tissue-Based Targe   •   Entrepreneur and philanthropist George L. Pla receives honorary doctorate at Cal State LA Commencement   •   KUBIENT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Kubient, I   •   AARP Illinois Statement on 2023 Spring Regular Legislative Session   •   Emler Swim School Activities Highlight Water Safety Month   •   100 MILLION WOMEN PER YEAR WILL NEED TO ADOPT MOBILE INTERNET TO CLOSE THE GENDER GAP BY 2030, GSMA REPORT REVEALS   •   Spark Math Accredited by Global K-12 STEM Program Stalwart STEM.org   •   Particular Audience Unveils Revolutionary ‘Adaptive Transformer Search’ Solving the $300 Billion eCommerce Search Pr   •   Ostentus Therapeutics, Inc., and City of Hope to Continue Studies of Novel OST Natural Products for Treatment of Leukemia and Ot   •   2024 Toyota Grand Highlander Touches Down in Driveways This Summer   •   The LYCRA Company’s Sustainability Director Joins Panel Discussion at the United Nations Conscious Fashion and Lifestyle N   •   FRB Hosts Career Field Trip with Girls Inc. of Long Island   •   THE NECESSITY RETAIL REIT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Ad   •   COHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc   •   U.S. News Unveils the 2023 Best Cars for Teens   •   IICCS Forum 2023: Accelerating Carbon Capture and Storage's Implementation in Indonesia   •   HighField Biopharmaceuticals’ HF1K16, a New Immuno-Oncology Drug, Shows Promise in Patients with Refractory Glioblastoma